Zoe Biosciences is a startup based in the United States.
Based in the United States, Zoe Biosciences is a startup.
Zoe Biosciences develops therapies targeting cardiometabolic diseases such as heart failure with preserved ejection fraction (HFpEF), obesity, and sarcopenia by focusing on pathways involving PAI-1 and APJ.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.